Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system disorders, successfully closed an oversubscribed Series B financing round, raising CHF 103 mio (approx. USD 112 mio). The round was co-led by the European healthcare focused
Tags :Homburger
Canacol Energy has entered into a USD 200 million revolving credit and guaranty agreement with Citigroup Global Markets, Deutsche Bank and JPMorgan Chase Bank as joint lead arrangers and joint bookrunners. Canacol is a natural gas
ADC Therapeutics, a commercial-stage biotechnology company headquartered in Lausanne, announced the pricing of an underwritten offering of 12 m ADCT shares currently owned by A.T. Holdings II, an affiliate of Auven Therapeutics Holding, at a
Credit Suisse, acting through its London branch, successfully completed its issuance of EUR 750 m aggregate principal amount of 5.550 per cent. senior notes due 2026. Credit Suisse issued the Notes through its London branch in two separate
The controlling shareholder of Reuge, the renowned music box producer, successfully completed the sale of a majority stake in the Reuge manufacture to the Swiss luxury watchmaker De Bethune. The independent watchmaker, known for its
Baker McKenzie has advised Tandem Diabetes Care, a global insulin delivery and diabetes technology company, on its purchase of AMF Medical, a privately held Swiss insulin patch pump developer. AMF Medical’s technology aligns well
Dufry has successfully closed the transfer of the 50.3% stake in Autogrill held by Edizione through a wholly owned subsidiary to Dufry. Dufry will launch a mandatory public exchange offer for the remaining Autogrill shares (excluding
Homburger has advised Raiffeisen Schweiz Genossenschaft on all legal, regulatory and tax aspects of the spin-off of its 6 branches into independent Raiffeisen banks. The team was led by René Bösch (financial market regulation) and
The Finnish private equity firm Juuri Partners Oy has announced its investment in DAF Group Oy, which is responsible for managing Subway’s business in Finland and Sweden through a long-term development agreement. Through the
UBS Group successfully completed its issuance of USD 1.75 bn in aggregate principal amount of Fixed Rate/Fixed Rate Callable Senior Notes due January 2027 and USD 2.25 bn in aggregate principal amount of Fixed Rate/Fixed Rate
